28 Oct 2020 13:30
Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.
28 October 2020
Zoetic International plc
("Zoetic" or the "Company" or the "Group")
Exercise of Share Options
Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, is pleased to announce that it has today issued 1,000,000 ordinary shares of 1 pence each ("Ordinary Shares") following the exercise of options under the Company's share option scheme (as announced on 8 October 2019), at an exercise price of 10 pence per Ordinary Share (the "Option Shares").
Application will be made to the London Stock Exchange for the Option Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List ("Admission"). It is expected that Admission will become effective and that dealings in the Option Shares on the Main Market of the London Stock Exchange will commence on or around 3 November 2020.
On Admission, the Company will have 195,570,034 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 195,570,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
**ENDS**
Enquiries
Zoetic International plc c/o IFC Advisory
Trevor Taylor, Co-CEO
Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656
Nick Harriss (Corporate Finance)
Nick Naylor (Corporate Finance)
Guy McDougall (Equity Sales)
IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630
Tim Metcalfe
Graham Herring
Florence Chandler